Significance of endogenous glucocorticoid sensitivity for airway eosinophilia in a murine model of allergy

Acta Oto-Laryngologica

Volumn 125, Issue 4, 2005, Pages 378-385

  Georén, Susanna ^a   Åhnblad, Peter ^a   Stjärne, Per ^a   Wikström, Anne Charlotte ^a   Stierna, Pontus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Eosinophil; Inflammation; Inhibition; Metyrapone; Ovalbumin; RU 486; Stress

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; METYRAPONE; MIFEPRISTONE; OVALBUMIN;

AIRWAY; ALLERGIC ASTHMA; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; DISEASE EXACERBATION; EOSINOPHIL; EOSINOPHILIA; INFLAMMATION; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SENSITIZATION; STEROID RELEASE; STRESS;

ADMINISTRATION, INTRANASAL; AIRWAY RESISTANCE; ANIMALS; ASTHMA; BONE MARROW; BRONCHI; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EOSINOPHILIA; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; LEUKOCYTE COUNT; LUNG; METYRAPONE; MICE; MICE, INBRED BALB C; MIFEPRISTONE; OVALBUMIN; RECEPTORS, GLUCOCORTICOID; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY MUCOSA; STRESS;

EID: 17144410387     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410025261     Document Type: Article

References (29)

1. Busse WW, Coffman RL, Gelfand EW, Kay AB. Mechanisms of persistent inflammation in asthma. A role for T cells and T-cell products. Am J Respir Crit Care Med 1995; 152:388-93.
2. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
3. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
4. Durham SR. Mechanisms of mucosal inflammation in the nose and lungs. Clin Exp Allergy 1998;28:11-6.
5. Finkelman FD, Katona IM, Urban JF Jr, Holmes J, Ohara J, Tung AS, et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988;141:2335-41.
6. Lopez AF, Sanderson CJ, Gamble JR, Campbell HR, Young IG, Vadas MA. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
7. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GMCSF. Blood 1989;73:1504-12.
8. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988;140:4245-52.
9. Lund VJ. Seasonal allergic rhinitis - a review of current therapy. Allergy Suppl 1996;51:5-7.
10. Mygind N. Progress in the drug management of allergic rhinitis. Eur Arch Otorhinolaryngol Suppl 1995;252:S68-72.
11. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect of inhaled corticosteroid on airway inflammation in asthma. Am Rev Respir Dis 1992;145:669-74.
12. Schleimer RP. Glucocorticosteroids: their mechanisms of action and use in allergic diseases. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse W, editors. Allergy: principles and practice. St Louis, MO: Mosby; 1998. p. 638-60.
13. Chrousos G. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332: 1351-62.
14. Sasaki H, Yanai M, Shimura S, Okayama H, Aikawa T, Sasaki T, et al. Late asthmatic response to Ascaris antigen challenge in dogs treated with metyrapone. Am Rev Respir Dis 1987;136:1459-65.
15. De Bie JJ, Hessel EM, Van Ark I, Van Esch B, Hofman G, Nijkamp FP, et al. Effect of dexamethasone and endogenous corticosterone on airway hyper responsiveness and eosinophilia in the mouse. Br J Pharmacol 1996;119:1484-90.
16. Peebles RS, Togias A, Bickel CA, Diemer FB, Hubbard WC, Schleimer RP. Endogenous glucocorticoids and antigen-induced acute and late phase pulmonary responses. Clin Exp Allergy 2000;30:1257-65.
17. Laue L, Kawai S, Brandon DD, Brightwell D, Barnes K, Knazek RA, et al. Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J Steroid Biochem 1988;29:591-8.
18. Leong KP, Huston D. Understanding the pathogenesis of allergic asthma using mouse models. Ann Allergy Asthma Immunol 2001;87:96-109.
19. Kung TT, Jones H, Adams III GK, Umland SP, Kreutner W, Egan RW, et al. Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol 1994;105:83-90.
20. Krinzman SJ, De Sanctis GT, Cernadas M, Kobzik L, Listman JA, Christiani DC, et al. T cell activation in a murine model of asthma. Am J Physiol 1996;271:L476-83.
21. Gaspar Elsas MIC, Joseph D, Elsas PX, Vargaftig BB. Rapid increase in bone-marrow eosinophil production and responses to eosinopoetic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 1997;17:404-13.
22. Zhao LL, Sjöstrand M, Gui ZH, Lindén A, Lötvall J, Jordana M. IL-12 regulates bone marrow eosinophilia and airway eotaxin levels induced by airway allergen exposure. Allergy 2000;55:749-56.
23. Das AM, Flower RJ, Hellewell PG, Teixeira MM, Perretti M. A novel model of allergic inflammation to study the effect of dexamethasone on eosinophilic recruitment. Br J Pharmacol 1997;121:97-104.
24. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-8.
25. Wei R, Listwak SJ, Sternberg EM. Lewis hypothalamic cells constitutively and upon stimulation express higher levels of mRNA for pro-inflammatory cytokines and related molecules: comparison with inflammatory resistant Fischer rat hypothalamic cells. J Neuroimmunol 2003;135: 10-28.
26. Buske-Kirschbaum A, Jobst S, Hellhammer DH. Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: pathologic factor or symptom? Ann N Y Acad Sci 1998;840:747-54.
27. Buske-Kirschbaum A, Hellhammer DH. Endocrine and immune response in chronic inflammatory skin disorders. Ann N Y Acad Sci 2003;992:231-40.
28. Eum SY, Créminin C, Hailé S, Lefort J, Vargaftig BB. Inhibition of airways inflammation by dexamethasone is followed by reduced bronchial hyperreactivity in BP2 mice. Clin Exp Allergy 1996;26:971-9.
29. Ebrecht M, Buske-Kirschbaum A, Hellhammer DH, Kern S, Rohleder N, Walker B, et al. Tissue specificity of glucocorticoid sensitivity in healthy adults. J Clin Endocrinol Metab 2000;85:3733-9.